Our goal is to improve the lives of others as much as we can. While our focus is grantmaking, what matters most to us is an organization’s potential for impact — not its tax status.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Binx to support work to incorporate Sherlock Biosciences's COVID-19 assay into Binx's point-of-care diagnostic platform.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in VST Bio to support the development of a novel treatment for stroke and traumatic brain disease.
Good Ventures LLC, at the recommendation of Open Philanthropy, invested in Riboscience to support work to test a new drug candidate against COVID-19.